← FDA Drug Approvals (Drugs@FDA)

GRAFAPEX

NDA · New Drug Application · Sponsor: MEDEXUS · Approved 2025-01-21

Drug application

FDA Application #

NDA214759

Application type

New Drug Application

Brand name

GRAFAPEX

Generic name

TREOSULFAN

Active ingredients

TREOSULFAN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MEDEXUS

Manufacturer

Medexus Pharma, Inc.

First approval

2025-01-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown